AD
Clinical trials for AD explained in plain language.
Never miss a new study
Get alerted when new AD trials appear
Sign up with your email to follow new studies for AD, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New pill aims to slow Alzheimer's: phase 2 trial underway
Disease control Recruiting nowThis Phase 2 trial tests whether TTYP01 tablets can slow cognitive decline in people with early Alzheimer's disease. About 180 participants aged 60-85 with mild cognitive impairment or mild dementia will receive either a low dose, high dose, or placebo for 78 weeks. Researchers w…
Matched conditions: AD
Phase: PHASE2 • Sponsor: Shanghai Auzone Biological Technology Co., Ltd. • Aim: Disease control
Last updated Jul 18, 2026 00:00 UTC
-
New injection aims to tame tough eczema
Disease control Recruiting nowThis early-stage trial tests an investigational drug called SSGJ-716, given as an injection, to see if it is safe and tolerable. The study first enrolls healthy adults to test a single dose, then moves to people with moderate-to-severe atopic dermatitis (a type of eczema) who rec…
Matched conditions: AD
Phase: PHASE1 • Sponsor: Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd. • Aim: Disease control
Last updated Jul 12, 2026 00:00 UTC